Ballew Neal

Ballew Neal, Chief Accounting Officer at Omega Healthcare Investors (OHI), has demonstrated a clear buy-side bias in their insider trading activity, with $37,402 in total purchases compared to just $2,768 in sales across 31 transactions—all involving OHI stock. The pattern shows consistent quarterly acquisitions, typically executed on the first day of January, April, July, and October, with purchases in the $6,200–$6,300 range per transaction. For example, on January 1, 2025, Neal acquired shares worth $6,210.74, followed by a smaller $378.50 transaction coded as "F" (likely a tax withholding or fee-related sale). Similar activity occurred on July 1, 2025 ($6,232 buy, $329.85 sell) and October 1, 2025 ($6,263.16 buy, $717.74 sell). Recent filings indicate no buys or sells in 2026, though three transactions on January 8 and 13 were reported with zero dollar values, suggesting adjustments to holdings rather than market trades. The bulk of Neal’s sales appear ancillary to acquisitions, likely tied to tax obligations or plan dispositions rather than discretionary divestment. Over the past two years, the data reflects a steady accumulation of OHI shares, reinforcing a long-term holding strategy with minimal sell-side activity. The absence of recent trades beyond administrative filings leaves the current position unchanged since the October 2025 transactions.